34
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Hb QIndia and its interaction with β–thalassaemia: a study of 64 cases from India

, , , &
Pages 160-163 | Accepted 21 Aug 2007, Published online: 23 May 2016
 

Abstract

Haemoglobin Q (Hb Q), a relatively uncommon α-chain structural Hb variant, has been reported either in the heterozygous state or interacting with β-thalassaemia. Individuals inheriting Hb Q generally are asymptomatic and are diagnosed by chance during population screening or as a part of a family study. This paper represents the first large study from India of 64 cases of Hb Q, documenting the haematological and molecular findings on 36 cases of Hb Q trait, 22 of Hb Q β-thalassaemia trait and three of Hb Q β-thalassaemia major, as well as a family of Hb Q homozygous cases. Hb Q is detected by Hb electrophoresis and chromatography. Hb Q levels in homozygous cases ranged from 32% to 35%, while in Hb Q heterozygotes the level was 20%. When there was an interaction of β-thalassaemia heterozygotes the level was 14%, and in interacting β-thalassaemia homozygotes the levels range from 7% to 9%. β-thalassaemia mutations were characterised in cases showing elevated Hb A2 levels, which were markedly reduced in the majority of cases in which β-thalassaemia was absent. Hb Q is rare and not a single homozygous case has been reported. However, Hb Q disease showed wide variation in clinical and haematological presentation in the same family.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.